MEDX Stock Overview
Designs, produces, and sells high-precision devices and services for the healthcare, consumer, and industrial end markets worldwide. More details
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 3/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 2/6 |
Rewards
Risk Analysis
medmix AG Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CHF 9.08 |
| 52 Week High | CHF 19.36 |
| 52 Week Low | CHF 8.93 |
| Beta | 0.76 |
| 11 Month Change | -8.93% |
| 3 Month Change | -14.34% |
| 1 Year Change | -51.96% |
| 33 Year Change | -79.16% |
| 5 Year Change | n/a |
| Change since IPO | -79.36% |
Recent News & Updates
Recent updates
medmix AG (VTX:MEDX) Looks Inexpensive After Falling 28% But Perhaps Not Attractive Enough
Aug 11
medmix (VTX:MEDX) Is Reinvesting At Lower Rates Of Return
Dec 19An Intrinsic Calculation For medmix AG (VTX:MEDX) Suggests It's 21% Undervalued
Oct 27Investors Could Be Concerned With medmix's (VTX:MEDX) Returns On Capital
Aug 16There May Be Reason For Hope In medmix's (VTX:MEDX) Disappointing Earnings
Feb 28medmix (VTX:MEDX) May Have Issues Allocating Its Capital
Jan 14Shareholder Returns
| MEDX | CH Medical Equipment | CH Market | |
|---|---|---|---|
| 7D | -3.4% | -3.3% | -1.4% |
| 1Y | -52.0% | 10.0% | 5.2% |
Return vs Industry: MEDX underperformed the Swiss Medical Equipment industry which returned 13.8% over the past year.
Return vs Market: MEDX underperformed the Swiss Market which returned 6.2% over the past year.
Price Volatility
| MEDX volatility | |
|---|---|
| MEDX Average Weekly Movement | 4.4% |
| Medical Equipment Industry Average Movement | 3.9% |
| Market Average Movement | 3.4% |
| 10% most volatile stocks in CH Market | 6.6% |
| 10% least volatile stocks in CH Market | 1.6% |
Stable Share Price: MEDX's share price has been volatile over the past 3 months compared to the Swiss market.
Volatility Over Time: MEDX's weekly volatility (4%) has been stable over the past year, but is still higher than 75% of Swiss stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1922 | 2,695 | n/a | www.medmix.swiss |
medmix AG designs, produces, and sells high-precision devices and services for the healthcare, consumer, and industrial end markets worldwide. The company operates through Dental, Drug Delivery, Surgery, Industry, and Beauty segments. The company offers dental products, including mixing tips, dispensers, needles, accessories, and service solutions for various applications, such as prosthetics, adhesives, restoratives, prevention, esthetics and endodontics; drug delivery devices that are used to inject fertility drugs and growth hormones; and to treat niche diabetes indications, osteoporosis, and rare diseases; and mixing and delivery devices which are used to inject bone tissue, and to apply hemostatic sealants for internal and external wound treatment during surgical procedures.
medmix AG Fundamentals Summary
| MEDX fundamental statistics | |
|---|---|
| Market cap | CHF 370.36m |
| Earnings (TTM) | -CHF 1.80m |
| Revenue (TTM) | CHF 479.70m |
0.8x
P/S Ratio-205.8x
P/E RatioIs MEDX overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| MEDX income statement (TTM) | |
|---|---|
| Revenue | CHF 479.70m |
| Cost of Revenue | CHF 323.40m |
| Gross Profit | CHF 156.30m |
| Other Expenses | CHF 158.10m |
| Earnings | -CHF 1.80m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
Feb 26, 2025
| Earnings per share (EPS) | -0.044 |
| Gross Margin | 32.58% |
| Net Profit Margin | -0.38% |
| Debt/Equity Ratio | 62.4% |
How did MEDX perform over the long term?
See historical performance and comparison